We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b.
- Authors
Atsukawa, Masanori; Tsubota, Akihito; Kondo, Chisa; Itokawa, Norio; Narahara, Yoshiyuki; Nakatsuka, Katsuhisa; Hashimoto, Satomi; Fukuda, Takeshi; Matsushita, Yoko; Kidokoro, Hideko; Kobayashi, Tamaki; Kanazawa, Hidenori; Sakamoto, Choitsu
- Abstract
Although the anti-hepatitis C virus (HCV) effect of statins in vitro and clinical efficacy of fluvastatin combined with Pegylated interferon (PEG-IFN)/ribavirin therapy for chronic hepatitis C (CHC) have been reported, the details of clinical presentation are largely unknown. We focused on viral relapse that influences treatment outcome, and performed a post-hoc analysis by using data from a randomized controlled trial.
- Publication
Journal of gastroenterology and hepatology, 2013, Vol 28, Issue 1, p51
- ISSN
1440-1746
- Publication type
Journal Article
- DOI
10.1111/j.1440-1746.2012.07267.x